Marilena Vrana: Building a Resilient Plasma Ecosystem in Europe
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“Four years at PPTA Europe, and the starting point has not changed: plasma-derived medicines (PDMPs) are a connection between people.
They begin with one person taking the time to donate for the benefit of another.
I spent my 4th year anniversary in Berlin with PPTA Germany for a constructive meeting on the legislative changes that affect everything from collection to patient access.
Europe has a solid ecosystem for plasma and PDMPs: diversity in collectors: public, private and non-profit, and several manufacturers with continued investment across the value chain. Its legislative framework should build on that strength.
A resilient European plasma ecosystem is not a nice-to-have. It is part of a healthcare system that cares for everyone who needs plasma-derived medicines.”
Other posts featuring Marilena Vrana on Hemostasis Today.
-
Nov 16, 2026, 10:48Tareq Abadl: Why the Kell Blood Group System Matters
-
Nov 16, 2026, 10:40TIF in China – Advancing Regional Cooperation in Thalassaemia Prevention and Care
-
Nov 16, 2026, 10:40Dhargam Aljebouri: A Milestone for Transfusion Medicine in Iraq
-
Nov 16, 2026, 10:35Arisha Patel: Why a Normal Blood Count Can Miss Iron Deficiency
-
Nov 16, 2026, 10:29Maxime Dely: The Needle Behind Every Donation
-
Nov 16, 2026, 10:24Hichem Selatna: Advancing Hematology Laboratory Automation
-
Nov 16, 2026, 10:20Erin Harris: CRISPR Gene Therapy in Children
-
Nov 16, 2026, 10:19Beverley Hunt: PE Knows No Age – Isaac’s Story
-
Nov 16, 2026, 10:08Abdul Mannan: When Normal Blood Counts Hide Iron Deficiency